Apoptosis and inflammation in renal reperfusion injury

Transplantation

Volumn 73, Issue 11, 2002, Pages 1693-1700

  Daemen, Marc A R C ^a   De Vries, Bart ^a   Buurman, Wim A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE;

APOPTOSIS; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; ENZYME ACTIVATION; HUMAN; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MORPHOLOGY; NEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 0037096712     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200206150-00001     Document Type: Review

References (101)

1. Outcome of transplantation of non-heart-beating donor kidneys
2. Delayed graft function in renal transplantation: Etiology, management and long-term significance
3. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia
4. Ueber pathologische verkalkungen und kalkmetastasen in den nieren
5. Die anämische nekrose der nierepithelien. Experimentelle untersuchung
6. The effects of temporary occlusion of the renal circulation in the rabbit
7. Mitochondrial and pH changes in the rat's kidney following interruption and restoration of the renal circulation
8. Superoxide radicals in feline intestinal ischemia
9. Defense strategies against hypoxia and hypothermia
10. Oxygen-derived free radicals in postischemic tissue injury
11. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear
12. Leukocyte-endothelial cell interactions in ischemia-reperfusion injury
13. Predominant role for C5b-9 in renal ischemia/reperfusion injury
14. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury
15. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
16. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs
17. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients
18. Acadesine inhibits neutrophil CD11b up-regulation in vitro and during in vivo cardiopulmonary bypass
19. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass
20. Necrosis and apoptosis in acute renal failure
21. Caspases: Enemies within
22. Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines
23. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition
24. A receptor for phosphatidylserine-specific clearance of apoptotic cells
25. Apoptosis. Gone but not forgotten
26. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis
27. Ischemic injury induces ADF relocalization to the apical domain of rat proximal tubule cells
28. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
29. Apoptosis. Death and transfiguration
30. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
31. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation
32. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis
33. Caspase 1-independant IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand
34. Two distinct cytokines released from a human aminoacyl-tRNA synthetase
35. ATP-dependent steps in apoptotic signal transduction
36. Apoptosis and necrosis: Different execution of the same death
37. Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis
38. Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo
39. Four deaths and a funeral: From caspases to alternative mechanisms
40. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury
41. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas
42. Review article: The role of tumor necrosis factor in renal ischemia- reperfusion injury
43. Cell death attenuation by 'Usurpin,' a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex
44. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
45. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
46. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat
47. Expression of bcl-2 and bax in regenerating rat renal tubulus following ischemic injury
48. Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure
49. Growth factors and cytokines in acute renal failure
50. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: Growth factors protect against c-myc-independent apoptosis
51. Mechanisms of insulin-like growth factor-I-induced accelerated recovery in experimental ischemic acute renal failure
52. Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules
53. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury
54. Neutrophils and acute ischemia-reperfusion injury
55. Postischemic renal injury is mediated by neutrophils and leukotrienes
56. Stress stimuli increase calcium-induced arachidonic acid release through phosphorylation of cytosolic phospholipase A2
57. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats
58. Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model
59. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury
60. Molecular mechanisms of leukocyte recruitment in the inflammatory process
61. Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin
62. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure
63. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation
64. Tissue destruction by neutrophils
65. The injury response: A concept linking nonspecific injury, acute rejection, and long term transplant outcomes
66. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse
67. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10
68. Ischemic injury induces altered MHC gene expression in kidney by an interferon-gamma-dependent pathway
69. Ischemia/reperfusion-induced IFN-gamma up-regulation: Involvement of IL-12 and IL-18
70. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice
71. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha
72. Activation of interferon-gamma inducing factor mediated by interleukin- 1beta converting enzyme
73. Role of IL-1 in renal ischemic reperfusion injury
74. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
75. Activated caspase-1 is not a central mediator of inflammation in the course of ischemia-reperfusion
76. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure
77. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7
78. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
79. Slow release of soluble TNF receptors by monocytes in vitro
80. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis
81. Early and delayed preconditioning: Differential mechanisms and additive protection
82. Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury
83. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation
84. Acute renal failure
85. From bench to clinic with apoptosis-based therapeutic agents
86. Modulating apoptosis: Current applications and prospects for future drug development
87. Alloreactivity and apoptosis in graft rejection and transplantation tolerance
88. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor
89. Cell death and cell proliferation in the control of normal and neoplastic tissue growth
90. First examples of peptidomimetic inhibitors of interleukin-1 beta converting enzyme
91. Potent and selective nonpeptide inhibitors of caspases 3 and 7
92. Effect of recombinant human insulin-like growth factor-1 on the inflammatory response to acute renal injury
93. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism
94. Exacerbated inflammatory response induced by insulin-like growth factor I treatment in rats with ischemic acute renal failure
95. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
96. Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
97. Exsanguinous metabolic support perfusion-a new strategy to improve graft function after kidney transplantation
98. Apoptosis in ischemia/reperfusion injury of human renal allografts
99. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver
100. Apoptosis is initiated by myocardial ischemia and executed during reperfusion
101. Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function